The University of Chicago Header Logo

Connection

Mohammad Atiq to Humans

Back to Details
This is a "connection" page, showing publications Mohammad Atiq has written about Humans.
Mohammad Atiq
Connection Strength
0.062
Humans
  1. Emerging treatment options for prostate cancer. Expert Rev Anticancer Ther. 2023 06; 23(6):625-631.
    View in: PubMed
    Score: 0.028
  2. Attenuation of SRC Kinase Activity Augments PARP Inhibitor-mediated Synthetic Lethality in BRCA2-altered Prostate Tumors. Clin Cancer Res. 2021 03 15; 27(6):1792-1806.
    View in: PubMed
    Score: 0.006
  3. Pembrolizumab-Induced Cold Agglutinin Disease. Am J Case Rep. 2020 Sep 05; 21:e924283.
    View in: PubMed
    Score: 0.006
  4. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer. Mol Oncol. 2020 08; 14(8):1881-1897.
    View in: PubMed
    Score: 0.006
  5. Significance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression. Clin Cancer Res. 2020 04 15; 26(8):2047-2064.
    View in: PubMed
    Score: 0.006
  6. A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2). Clin Cancer Res. 2019 07 15; 25(14):4480-4492.
    View in: PubMed
    Score: 0.005
  7. The Role of Immunotherapy and Radiation Therapy in Tumor Chemosensitivity in Advanced Head and Neck Cancer. Am J Case Rep. 2018 Oct 18; 19:1241-1244.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.